Selective association of endogenous ouabain with subclinical organ damage in treated hypertensive patients

Journal of Human Hypertension

Volumn 25, Issue 2, 2011, Pages 122-129

  Nagy, G ^a,b   Gaszner, B ^b   Lanyi E ^b   Marko L ^a   Feher E ^b   Cseh, J ^a   Kszegi, T ^b   Betlehem, J ^b   Sulyok, E ^b   Cziraki A ^b   Wittmann, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

arterial stiffness; endogenous ouabain; nighttime blood pressure; subclinical organ damage

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CATECHOLAMINE DERIVATIVE; OUABAIN;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NIGHT; ORGAN INJURY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

EID: 78651406208     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.24     Document Type: Article

References (37)

1. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F et al. Identification and char-acterization of an ouabain-like compound from human plasma. Proc Natl Acad Sci USA 1991; 88: 6259-6263.
2. Bagrov AY, Shapiro JI. Endogenous digitalis: patho-physiologic roles and therapeutic applications. Nat Clin Pract Nephrol 2008; 4: 378-392.
3. Manunta P, Ferrandi M, Bianchi G, Hamlyn JH. Endogenous ouabain in cardiovascular function and disease. JHypertens 2009; 27: 9-18.
4. Stella P, Manunta P, Mallamaci F, Melandri M, Spotti D, Tripepi G et al. Endogenous ouabain and cardio-myopathy in dialysis patients. J Intern Med 2008; 263: 274-280.
5. Bauer N, Müller-Ehmsen J, Krämer U, Hambarchian N, Zobel C, Schwinger RH et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of ß-blockade and angiotensin-converting enzyme inhibition. Hypertension 2005; 45: 1024-1028.
6. Balzan S, Montali U, Biver P, Ghione S. Antidigoxin antibodies neutralize the effect of newborn endogen-ous digitalis-like factor on erythrocyte 86Rb uptake. J Nucl Biol Med 1991; 35: 38-40.
7. Bagrov AY, Shapiro JI, Fedorova OV. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol Rev 2009; 61: 9-38.
8. Blaustein MP, Zhang J, Chen L, Song H, Raina H, Kinsey SP et al. The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009; 53: 291-298.
9. Dostanic-Larson I, Lorenz JN, Van Huysse JW, Neu-mann JC, Moseley AE, Lingrel JB. Physiological role of the alpha1-and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site. Am J Physiol Regul Integr Comp Physiol 2006; 290: R524-R528.
10. Huang BS, Huang X, Harmsen E, Leenen FHH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension 1994; 23: 1087-1090.
11. Skoumal R, Szokodi I, Aro J, Földes G, Göoz M, Seres L et al. Involvement of endogenous ouabain-like com-pound in cardiac hypertrophic process in vivo. Life Sci 2007; 80: 1303-1310.
12. Liu J, Tian J, Haas M, Shapiro JI, Askari A, Xie Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 2000; 275: 27838-27844.
13. Aydemir-Koksoy A, Abramowitz J, Allen JC. Ouabain-induced signaling and vascular smooth muscle cell proliferation. J Biol Chem 2001; 276: 46605-46611.
14. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EG et al. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimen-tal uremic cardiomyopathy. Hypertension 2007; 49: 215-224.
15. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M et al. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999; 34: 450-456.
16. Balzan S, Neglia D, Ghione S, D'Urso G, Baldacchino MC, Montali U et al. Increased circulating levels of ouabain-like factor in patient with asymptomatic left ventricular dysfunction. Eur J HeartFail 2001; 3: 165-171.
17. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670.
18. Grossmann M, J Amieson MJ, Kirch W. Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteers. Eur J Clin Invest 1998; 28: 701-706.
19. Kirch C, Grossmann M, Fischer S, Neumeister V, Kirch W. Effect of digoxin on circadian blood pressure values in patients with congestive heart failure. Eur J Clin Invest 2000; 30: 285-289.
20. Grossmann M. Effects of cardiac glycosides on 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure. Eur J Clin Invest 2001; 31(Suppl 2): S26-S30.
21. Clerico A, Giampietro O, Gregori G, Del Chicca MG, Bertoli S, Miccoli R et al. Excretion of digoxin-like immunoreactivity in urine ofnormal subjects: Correla-tions with excretion of creatinine and electrolytes. Clin Chem 1988; 34: 554-556.
22. Vakkuri O, Arnason SS, Joensuu P, Jalonen J, Vuoltee-naho O, Leppäluoto J. Radioionated tyroly-ouabain and measurement of a circulating ouabain-like com-pound. Clin Chem 2001; 47: 95-101.
23. Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J HeartFail 2004; 6: 365-368.
24. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ et al. American Society of Echocardio-graphy. American Society of Echocardiography recom-mendations for use of echocardiography in clinical trials; a report from the American Society of Echocar-diography's Guidelines and Standards Committee and The Task Force on Echocardiography in Clinical Trials. J Am SocEchocardiogr 2004; 17: 1086-1119.
25. Niki K, Sugawara M, Chang D, Harada A, Okada T, Sakai R et al. A new noninvasive measurement system for wave intensity: evaluation of carotid arterial wave intensity and reproducibility. Heart Vessels 2002; 17: 12-21.
26. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Sacchi N et al. Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension. J Hypertens 1996; 14: 1167-1173.
27. Giles TD. Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens Suppl 2006; 24: 11-16.
28. Tripodi G, Citterio L, Kouznetsova T, Lanzani C, Florio M, Modica R et al. Steroid biosythesis and renal excretion in human essential hypertension: associa-tion with blood pressure and endogenous ouabain. Am J Hypertens 2009; 22: 357-363.
29. Vakkuri O, Arnason SS, Pouta A, Vuolteenaho O, Leppäluoto J. Radioimmunoassay of plasma oaubain in healthy and pregnant individuals. J Endocrinol 2000; 165: 669-677.
30. Manunta P, Iacoviello M, Forleo C, Messaggio E, Hamlyn JM, Lucarelli K et al. High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals. J Hypertens 2005; 23: 1677-1681.
31. Crabos M, Ausiello DA, Haupert Jr GT, Cantiello HF. Atrial natriuretic peptide regulates release of Na+, K+-ATPase inhibitor from rat brain. Am J Physiol 1988; 254: F912-F917.
32. Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Athero-sclerosis Risk in Communities Study. Circulation 1995; 91: 1432-1443.
33. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
34. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial siffness and pulse pressure in hypertension and cardiovascular disease. Circulation 2003; 107: 2864-2869.
35. Briones AM, Xavier FE, Arribas SM, González MC, Rossoli LV, Alonso MJ et al. Alterations in structure and mechanics of resistance arteries from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 2006; 291: H193-H201.
36. Kawamoto R, Kohara K, Tabara Y, Miki T, Ohtsuka N, Kusunoki T et al. An association between decreased estimated glomerular filtration rate and arterial stiff-ness. Intern Med 2008; 47: 593-598.
37. Nakagawa N, Takahashi F, Chinda J, Kobayashi M, Hayashi Y, Abe M et al. A newly estimated glomerular filtration rate is independently associated with arterial stiffness in Japanase patients. Hypertens Res 2008; 31: 193-201.